Literature DB >> 16972170

Pharmacophore model for bile acids recognition by the FPR receptor.

Cristina Ferrari1, Antonio Macchiarulo, Gabriele Costantino, Roberto Pellicciari.   

Abstract

Formyl-peptide receptors (FPRs) belong to the family A of the G-protein coupled receptor superfamily and include three subtypes: FPR, FPR-like-1 and FPR-like-2. They have been involved in the control of many inflammatory processes promoting the recruitment and infiltration of leukocytes in regions of inflammation through the molecular recognition of chemotactic factors. A large number of structurally diverse chemotypes modulate the activity of FPRs. Newly identified antagonists include bile acids deoxycholic acid (DCA) and chenodeoxycholic acid (CDCA). The molecular recognition of these compounds at FPR receptor was computationally investigated using both ligand- and structure-based approaches. Our findings suggest that all antagonists bind at the first third of the seven helical bundles. A closer inspection of bile acid interaction reveals a number of unexploited anchor points in the binding site that may be used to aid the design of new potent and selective bile acids derivatives at FPR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972170     DOI: 10.1007/s10822-006-9055-1

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  32 in total

1.  Topological side-chain classification of beta-turns: ideal motifs for peptidomimetic development.

Authors:  Tran Trung Tran; Jim McKie; Wim D F Meutermans; Gregory T Bourne; Peter R Andrews; Mark L Smythe
Journal:  J Comput Aided Mol Des       Date:  2005-11-23       Impact factor: 3.686

2.  The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.

Authors:  E Schiffmann; H V Showell; B A Corcoran; P A Ward; E Smith; E L Becker
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

3.  The interaction of 3,5-pyrazolidinedione drugs with receptors for f-Met-Leu-Phe on human neutrophil leukocytes: a study of the structure-activity relationship.

Authors:  L Levesque; R C Gaudreault; F Marceau
Journal:  Can J Physiol Pharmacol       Date:  1991-03       Impact factor: 2.273

4.  The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1.

Authors:  Y Le; H Yazawa; W Gong; Z Yu; V J Ferrans; P M Murphy; J M Wang
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

5.  Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.

Authors:  W F Stenson; J Mehta; I Spilberg
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

6.  Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects.

Authors:  A Dalpiaz; M E Ferretti; R Pecoraro; E Fabbri; S Traniello; A Scatturin; S Spisani
Journal:  Biochim Biophys Acta       Date:  1999-06-15

7.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.

Authors:  H Wang; J Chen; K Hollister; L C Sowers; B M Forman
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

8.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

9.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

10.  Regulatory effects of deoxycholic acid, a component of the anti-inflammatory traditional Chinese medicine Niuhuang, on human leukocyte response to chemoattractants.

Authors:  Xin Chen; Richard Daniel Mellon; Lu Yang; Huifang Dong; Joost J Oppenheim; Ola Mae Zack Howard
Journal:  Biochem Pharmacol       Date:  2002-02-01       Impact factor: 5.858

View more
  12 in total

1.  Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Liliya N Kirpotina; Lars Brive; Claes Dahlgren; Mark A Jutila; Mark T Quinn
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

Review 2.  Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.

Authors:  I A Schepetkin; A I Khlebnikov; M P Giovannoni; L N Kirpotina; A Cilibrizzi; M T Quinn
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 3.  The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.

Authors:  Thijs W H Pols; Lilia G Noriega; Mitsunori Nomura; Johan Auwerx; Kristina Schoonjans
Journal:  J Hepatol       Date:  2010-12-09       Impact factor: 25.083

Review 4.  The bile acid membrane receptor TGR5: a valuable metabolic target.

Authors:  Thijs W H Pols; Lilia G Noriega; Mitsunori Nomura; Johan Auwerx; Kristina Schoonjans
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

5.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

Review 6.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

7.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

Review 8.  Bile acids: emerging role in management of liver diseases.

Authors:  Amon Asgharpour; Divya Kumar; Arun Sanyal
Journal:  Hepatol Int       Date:  2015-08-29       Impact factor: 6.047

9.  Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Authors:  Maria Paola Giovannoni; Igor A Schepetkin; Agostino Cilibrizzi; Letizia Crocetti; Andrei I Khlebnikov; Claes Dahlgren; Alessia Graziano; Vittorio Dal Piaz; Liliya N Kirpotina; Serena Zerbinati; Claudia Vergelli; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2013-04-08       Impact factor: 6.514

10.  Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice.

Authors:  Sooghee Chang; Youn-Hee Kim; Young-Joo Kim; Young-Woo Kim; Sungyoon Moon; Yong Yook Lee; Jin Sun Jung; Youngsoo Kim; Hi-Eun Jung; Tae-Joo Kim; Taek-Chin Cheong; Hye-Jung Moon; Jung-Ah Cho; Hang-Rae Kim; Dohyun Han; Yirang Na; Seung-Hyeok Seok; Nam-Hyuk Cho; Hai-Chon Lee; Eun-Hee Nam; Hyosuk Cho; Murim Choi; Nagahiro Minato; Seung-Yong Seong
Journal:  Front Immunol       Date:  2018-09-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.